Efficacy of Monthly Ibandronate in Women With Rheumatoid Arthritis and Reduced Bone Mineral Density Receiving Long-term Glucocorticoids.
Phase of Trial: Phase IV
Latest Information Update: 08 Mar 2017
At a glance
- Drugs Ibandronic acid (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- 10 Jun 2017 Biomarkers information updated
- 01 Feb 2017 Results published in the Clinical Therapeutics
- 13 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.